Evidence map›Paper›PMID 27043505›Full record

ReviewMolecules (Basel, Switzerland)2016

Sinigrin and Its Therapeutic Benefits.

Anisha Mazumder, Anupma Dwivedi, Jeanetta du Plessis

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 185 citations in OpenAlex.

  1. Trial
  2. Article
  3. Phytochemistry and Application of White Mustard (Molecules (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Coixol and Sinigrin fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Exploring the inhibitory effects ofFood science and biotechnology · 2025
    Article
  8. Plants (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Protective Effects of aMetabolites · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anisha MazumderCentre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. anishamajumdar@gmail.com.
Anupma DwivediCentre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. anupma.feb1@gmail.com.
Jeanetta du PlessisCentre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. Jeanetta.DuPlessis@nwu.ac.za.
North-West University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinigrin (allyl-glucosinolate or 2-propenyl-glucosinolate) is a natural aliphatic glucosinolate present in plants of the Brassicaceae family, such as broccoli and brussels sprouts, and the seeds of Brassica nigra (mustard seeds) which contain high amounts of sinigrin. Since ancient times, mustard has been used by mankind for its culinary, as well as medicinal, properties. It has been systematically described and evaluated in the classical Ayurvedic texts. Studies conducted on the pharmacological activities of sinigrin have revealed anti-cancer, antibacterial, antifungal, antioxidant, anti-inflammatory, wound healing properties and biofumigation. This current review will bring concise information about the known therapeutic activities of sinigrin. However, the information on known biological activities is very limited and, hence, further studies still need to be conducted and its molecular mechanisms also need to be explored. This review on the therapeutic benefits of sinigrin can summarize current knowledge about this unique phytocompounds.

Indexed as

Anti-Inflammatory AgentsAntioxidantsBrassicaGlucosinolatesHumansInflammationSeedsWound HealingAnti-Inflammatory AgentsAntioxidantsGlucosinolatessinigrinanticancerBrassicaceae familyglucosinolatesmustardmyrosinasesinigrin

Identifiers

PMID27043505
PMCPMC6273501
OpenAlexW2323956675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.